KMB -Aimmugen Vaccine

A hepatitis A vaccine produced by culturing hepatitis A virus on African green monkey kidney GL37 cells, followed by purification and inactivation. Aimmugen was developed in Japan. It is lyophilized and contains no adjuvants. Aimmugen can be administered subcutaneously or intramuscularly to people of all ages. General immunization requires 3 administrations, however, when rapid immunization is needed, 2 administrations at 0 and 2 weeks may be adequate.